Acuta Capital Partners, LLC Ac Immune Sa Transaction History
Acuta Capital Partners, LLC
- $52.7 Million
- Q1 2025
A detailed history of Acuta Capital Partners, LLC transactions in Ac Immune Sa stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 100,000 shares of ACIU stock, worth $169,000. This represents 0.19% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$169,000% of portfolio
0.19%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ACIU
# of Institutions
45Shares Held
27.4MCall Options Held
4.8KPut Options Held
22.2K-
Bvf Inc San Francisco, CA19.8MShares$33.5 Million1.63% of portfolio
-
Black Rock Inc. New York, NY2.61MShares$4.41 Million0.0% of portfolio
-
Wells Fargo & Company San Francisco, CA998KShares$1.69 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny803KShares$1.36 Million0.0% of portfolio
-
Platinum Investment Management LTD Sydney Australia 2000, C3739KShares$1.25 Million0.09% of portfolio
About AC Immune SA
- Ticker ACIU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,413,504
- Market Cap $141M
- Description
- AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...